Colin Correnti

3.0k total citations · 1 hit paper
26 papers, 872 citations indexed

About

Colin Correnti is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Colin Correnti has authored 26 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Oncology and 7 papers in Immunology. Recurrent topics in Colin Correnti's work include CAR-T cell therapy research (7 papers), Virus-based gene therapy research (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Colin Correnti is often cited by papers focused on CAR-T cell therapy research (7 papers), Virus-based gene therapy research (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Colin Correnti collaborates with scholars based in United States, Spain and South Africa. Colin Correnti's co-authors include Roland K. Strong, Ashok D. Bandaranayake, Mario Ruiz, Mesfin Gewe, Matthew C. Clifton, Marı́a D. Ganfornina, Diego Sánchez, David J. Rawlings, Stanley R. Riddell and Michelle Brault and has published in prestigious journals such as Science, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Colin Correnti

26 papers receiving 861 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Designed protein logic to target cells with precise combinations of surface antigens

2020 144 citations Marc J. Lajoie, Scott E. Boyken et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Colin Correnti United States	15	428	219	177	118	116	26	872
Ewa D. Micewicz United States	15	304 0.7×	168 0.8×	118 0.7×	196 1.7×	86 0.7×	31	797
Julien Fassy France	8	275 0.6×	301 1.4×	116 0.7×	73 0.6×	36 0.3×	12	823
Kyriaki Tsalkitzi France	5	292 0.7×	403 1.8×	184 1.0×	69 0.6×	34 0.3×	6	870
Xueni Chen United States	18	524 1.2×	293 1.3×	72 0.4×	114 1.0×	192 1.7×	34	1.3k
Sheng‐Hao Chao Singapore	19	925 2.2×	188 0.9×	289 1.6×	34 0.3×	135 1.2×	42	1.3k
Mayumi Ishihara United States	18	728 1.7×	185 0.8×	66 0.4×	105 0.9×	19 0.2×	35	1.1k
Andrew Chen United States	13	788 1.8×	133 0.6×	155 0.9×	70 0.6×	22 0.2×	29	1.1k
Sunjoo Jeong South Korea	26	1.4k 3.4×	138 0.6×	234 1.3×	138 1.2×	45 0.4×	68	1.9k
Trinidad Hernández‐Caselles Spain	19	346 0.8×	525 2.4×	159 0.9×	100 0.8×	20 0.2×	34	1.1k
Catherine Kettleborough United Kingdom	15	610 1.4×	270 1.2×	205 1.2×	234 2.0×	26 0.2×	30	1.3k

Countries citing papers authored by Colin Correnti

Since Specialization

Citations

This map shows the geographic impact of Colin Correnti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Correnti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Correnti more than expected).

Fields of papers citing papers by Colin Correnti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin Correnti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Correnti. The network helps show where Colin Correnti may publish in the future.

Co-authorship network of co-authors of Colin Correnti

This figure shows the co-authorship network connecting the top 25 collaborators of Colin Correnti. A scholar is included among the top collaborators of Colin Correnti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin Correnti. Colin Correnti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rupert, Peter B., Della Friend, Benjamin G. Hoffstrom, et al.. (2023). Novel mesothelin antibodies enable crystallography of the intact mesothelin ectodomain and engineering of potent, T cell-engaging bispecific therapeutics. SHILAP Revista de lepidopterología. 3. 3 indexed citations

Crook, Zachary R., Emily J. Girard, Mi‐Youn Brusniak, et al.. (2022). Ex silico engineering of cystine-dense peptides yielding a potent bispecific T cell engager. Science Translational Medicine. 14(645). eabn0402–eabn0402. 7 indexed citations

Srivastava, Shivani, Jenny L. Smith, Amanda R. Leonti, et al.. (2021). Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia. Clinical Cancer Research. 27(20). 5718–5730. 17 indexed citations

Gopalakrishnapillai, Anilkumar, Colin Correnti, Ashok D. Bandaranayake, et al.. (2021). Immunotherapeutic Targeting of Mesothelin Positive Pediatric AML Using Bispecific T Cell Engaging Antibodies. Cancers. 13(23). 5964–5964. 6 indexed citations

Godwin, Colin D., George S. Laszlo, Tinh-Doan Phi, et al.. (2021). Targeting the membrane-proximal C2-set domain of CD33 for improved CD33-directed immunotherapy. Leukemia. 35(9). 2496–2507. 12 indexed citations

Correnti, Colin, Lindsey Doyle, Carla A. Jaeger-Ruckstuhl, et al.. (2020). Engineering and functionalization of large circular tandem repeat protein nanoparticles. Nature Structural & Molecular Biology. 27(4). 342–350. 14 indexed citations

Jaeger-Ruckstuhl, Carla A., Magdalena Hinterbrandner, Sabine Höpner, et al.. (2020). TNIK signaling imprints CD8+ T cell memory formation early after priming. Nature Communications. 11(1). 1632–1632. 17 indexed citations

Girard, Emily J., Gene Hopping, Fiona Pakiam, et al.. (2020). A potent peptide-steroid conjugate accumulates in cartilage and reverses arthritis without evidence of systemic corticosteroid exposure. Science Translational Medicine. 12(533). 32 indexed citations

Lajoie, Marc J., Scott E. Boyken, Alexander I. Salter, et al.. (2020). Designed protein logic to target cells with precise combinations of surface antigens. Science. 369(6511). 1637–1643. 144 indexed citations breakdown →

10.

Pattwell, Siobhan S., Sonali Arora, Patrick J. Cimino, et al.. (2020). A kinase-deficient NTRK2 splice variant predominates in glioma and amplifies several oncogenic signaling pathways. Nature Communications. 11(1). 2977–2977. 26 indexed citations

11.

Leonti, Amanda R., et al.. (2020). Therapeutic Targeting of Mesothelin in Acute Myeloid Leukemia with Chimeric Antigen Receptor T Cell Therapy. Blood. 136(Supplement 1). 11–11. 1 indexed citations

12.

Correnti, Colin, Mesfin Gewe, Christopher Mehlin, et al.. (2018). Screening, large-scale production and structure-based classification of cystine-dense peptides. Nature Structural & Molecular Biology. 25(3). 270–278. 48 indexed citations

13.

Peng, Tao, R. Savanh Chanthaphavong, Khamsone Phasouk, et al.. (2017). Keratinocytes produce IL-17c to protect peripheral nervous systems during human HSV-2 reactivation. The Journal of Experimental Medicine. 214(8). 2315–2329. 47 indexed citations

14.

McGuire, Andrew T., Matthew D. Gray, Pia Dosenovic, et al.. (2016). Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice. Nature Communications. 7(1). 10618–10618. 118 indexed citations

15.

Finton, Kathryn A. K., Kevin Larimore, H. Benjamin Larman, et al.. (2013). Autoreactivity and Exceptional CDR Plasticity (but Not Unusual Polyspecificity) Hinder Elicitation of the Anti-HIV Antibody 4E10. PLoS Pathogens. 9(9). e1003639–e1003639. 40 indexed citations

16.

Allred, Benjamin E., Colin Correnti, Matthew C. Clifton, Roland K. Strong, & Kenneth N. Raymond. (2013). Siderocalin Outwits the Coordination Chemistry of Vibriobactin, a Siderophore of Vibrio cholerae. ACS Chemical Biology. 8(9). 1882–1887. 34 indexed citations

17.

Ruiz, Mario, Marı́a D. Ganfornina, Colin Correnti, Roland K. Strong, & Diego Sánchez. (2013). Ligand binding‐dependent functions of the lipocalin NLaz: an in vivo study in Drosophila. The FASEB Journal. 28(4). 1555–1567. 14 indexed citations

18.

Correnti, Colin, Věra Richardson, Ashok D. Bandaranayake, et al.. (2012). Siderocalin/Lcn2/NGAL/24p3 Does Not Drive Apoptosis Through Gentisic Acid Mediated Iron Withdrawal in Hematopoietic Cell Lines. PLoS ONE. 7(8). e43696–e43696. 40 indexed citations

19.

Correnti, Colin & Roland K. Strong. (2012). Mammalian Siderophores, Siderophore-binding Lipocalins, and the Labile Iron Pool. Journal of Biological Chemistry. 287(17). 13524–13531. 94 indexed citations

20.

Correnti, Colin, Matthew C. Clifton, Rebecca J. Abergel, et al.. (2011). Galline Ex-FABP Is an Antibacterial Siderocalin and a Lysophosphatidic Acid Sensor Functioning through Dual Ligand Specificities. Structure. 19(12). 1796–1806. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact